CVT Surgery - Other

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Lung 91%
3. Non-Small Cell Lung Carcinoma 88%
4. Neoplasms 74%
5. Lung Transplantation 70%
6. Thorax 65%
7. Robotics 62%
8. Esophagectomy 61%
9. Neoplasm Staging 57%
10. Esophageal Neoplasms 45%
11. Transplant Recipients 40%
12. Thymic epithelial tumor 34%
13. Survival 31%
14. Video-Assisted Thoracic Surgery 30%
15. Surgeons 28%
16. Positron-Emission Tomography 28%
17. Therapeutics 27%
18. Lymph Nodes 27%
19. Bronchiolitis Obliterans 25%
20. Neoplasm Metastasis 25%
21. Thymoma 22%
22. Thymectomy 21%
23. Flap Endonucleases 21%
24. Malignant Mesothelioma 21%
25. Biomarkers 20%
26. Recurrence 20%
27. Databases 20%
28. CpG Islands 19%
29. Autoantibodies 19%
30. Diverticulum 18%
31. Positron Emission Tomography Computed Tomography 18%
32. Mesothelioma 17%
33. Biopsy 17%
34. Radiotherapy 17%
35. Empyema 17%
36. Adenocarcinoma 17%
37. ferumoxtran-10 16%
38. Small Cell Lung Carcinoma 16%
39. Stomach 16%
40. Gastroesophageal Reflux 16%
41. Myasthenia Gravis 16%
42. Lymph Node Excision 16%
43. Mortality 16%
44. Thoracotomy 15%
45. Checklist 15%
46. Intensity-Modulated Radiotherapy 15%
47. Coccidioidomycosis 15%
48. Burkholderia cepacia 15%
49. DNA Methylation 15%
50. Cystic Fibrosis 14%
51. Superior Vena Cava Syndrome 14%
52. Mediastinoscopy 14%
53. Mucormycosis 14%
54. Tomography 14%
55. Mutation 14%
56. Thoracic Wall 14%
57. Thoracic Surgery 13%
58. Transplants 13%
59. Chondrosarcoma 13%
60. Minimally Invasive Surgical Procedures 13%
61. Esophageal Squamous Cell Carcinoma 12%
62. Radiofrequency Ablation 12%
63. Bronchoscopy 12%
64. Leiomyoma 12%
65. Fistula 12%
66. Insulin 12%
67. Deoxyglucose 12%
68. Thoracic Duct 12%
69. Public Opinion 11%
70. Tissue Donors 11%
71. Clinical Trials 11%
72. Thymus Neoplasms 11%
73. Torque 11%
74. Length of Stay 11%
75. glycerol-insulin 11%
76. Epithelial Cells 11%
77. Lung Diseases 11%
78. Wounds and Injuries 11%
79. Equipment and Supplies 11%
80. Antibodies 10%
81. Patient Safety 10%
82. Morbidity 10%
83. Solitary Pulmonary Nodule 10%
84. Breast Neoplasms 10%
85. Infections 10%
86. Serum 10%
87. Costs and Cost Analysis 10%
88. phosphatase-1 kinase 10%
89. Mediastinum 9%
90. imidazolecarboxamide 9%
91. Chylothorax 9%
92. Drug Therapy 9%
93. Oxygen 9%
94. Population 9%
95. Multicenter Studies 9%
96. Safety 9%
97. Multidetector Computed Tomography 9%
98. Paraneoplastic Endocrine Syndromes 9%
99. Biostatistics 9%
100. Leukemia 9%